so they dosed 2 per week over 10 weeks for a total 20 participants, and expect completion 2Q2023. Remaining results should be then weekly until late June.
keen to see what the whole cohort reveals.
- Forums
- ASX - By Stock
- CPH
- Ann: Halucenex Phase II Clinical Trial Update
Ann: Halucenex Phase II Clinical Trial Update, page-46
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CPH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online